Results 311 to 320 of about 8,662,910 (358)
Some of the next articles are maybe not open access.

Drug–drug interactions involving new antiretroviral drugs and drug classes

Current Opinion in Infectious Diseases, 2009
The aim of this article is to review the available data on new antiretroviral agents and the drug-drug interactions studied so far.Several new drugs have been recently approved or are under development for the treatment of HIV infection. The pharmacokinetics of these agents is being studied to provide information about safety and efficacy, and ...
Jesse, Soodalter   +2 more
openaire   +2 more sources

Drug safety, drug quality, drug analysis

Journal of Pharmaceutical and Biomedical Analysis, 2008
Controlling and minimizing the side effects of drugs are the key issues in assuring the safety of drug therapy. Since side effects are inherent properties of the drug material, these cannot be influenced by drug analysts. At the same time drug analysts play a predominant role in assuring the quality of bulk drug materials and drug formulations and this
openaire   +2 more sources

Drug—Drug Interaction of Antifungal Drugs

ChemInform, 2006
AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Toshiro Niwa   +2 more
openaire   +1 more source

Drug Prescribing: Drug-Drug Interactions.

FP essentials, 2021
Drug-drug interactions (DDIs) occur when one drug adds to or diminishes the effect of another drug (ie, pharmacodynamic interaction) or affects the absorption, distribution, metabolism, or excretion of another drug (ie, pharmacokinetic interaction).
Brianna M, McQuade, Ashley, Campbell
openaire   +1 more source

Interactive Associations of Drug–Drug and Drug–Drug–Drug with IIA Subdomain of Human Serum Albumin

Molecular Pharmaceutics, 2012
Owing to advantageous biochemical and pharmacological properties of human serum albumin (HSA), HSA-based drug carrier is playing an increasing role in the clinical setting. Since the IIA subdomain of HSA is a big hydrophobic cavity, we proposed that HSA delivers multiple drugs simultaneously docking on the IIA subdomain and that drugs may influence ...
Feng, Yang   +6 more
openaire   +2 more sources

Drug—Drug Interactions in the Elderly

Annals of Pharmacotherapy, 2002
OBJECTIVE: To detect the frequency of potential drug—drug interactions (DDIs) in an outpatient group of elderly people in 6 European countries, as well as to describe differences among countries. DATA SOURCES AND METHODS: Drug use data were collected from 1601 elderly persons living in 6 European countries.
Ingeborg K Björkman   +23 more
openaire   +2 more sources

Iron as a Drug and Drug–Drug Interactions

2009
• Bioavailabiltiy of oral iron may be enhanced in the presence of reducing agents such as ascorbic acid.
Tracy M. Hagemann, Teresa V. Lewis
openaire   +1 more source

Drug-Drug Interactions of Antimalarial Drugs

2018
Malaria is the most important parasitic disease of humans accounting for high morbidity and mortality rates in the tropical and subtropical countries of Africa, Asia, and the Americas. Combination chemotherapy is recommended for treatment of acute uncomplicated malaria as a result of widespread drug resistance.
Waheed A. Adedeji   +3 more
openaire   +1 more source

Drug-Drug Interactions with Antipsychotics

CNS Spectrums, 2007
Recognizing drug-drug interactions (DDIs) has become increasingly important as the country's demographics have aged, resulting in more complex medication regimens. Budnitz and colleagues highlighted the frequency of adverse drug reactions (ADRs) and the substantial morbidity that results.
openaire   +2 more sources

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Home - About - Disclaimer - Privacy